GNI GROUP LTD.
Contact Us
About Us
About Us TOP
Message
Business Model
Main Products
Management Policy
Company Overview
Board of Directors
Main Group Structure
Office
Corporate governance
R&D
R&D TOP
Pipeline
Discovery Research
Research publications
Investor Relations
Investor Relations TOP
IR News
Information
IR Materials
IR Calendar
IR Email Subscription
Electronic Public Notices
Sustainability/ESG
Sustainability/ESG TOP
Sustainability Initiatives
ESG Data
Contact Us
Site Map
Privacy Policy
Terms of Use
ソーシャルメディアポリシー
Information
トップページ
Information
All
2026
2025
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2010/03/17
Drug Discovery Technology World Asia 2010
2010/03/15
Pre-IND Studies of F1013 For Liver Failure Initiated In China And Update On Drug Pipeline Development
2010/02/23
Update On Progress Of F647 NDA Filing
2010/02/10
Announcement of cancellation of the notes of Going concern
2010/02/04
Announcement of the 9th Annual General Shareholder Meeting
2010/02/04
Notice of Granting Stock Option to Consultants
2010/01/27
Notice for Exercise of the 30th Round of Stock Options in January, 2010 and Completion of its Exercise
2010/01/25
Notice for Large Volume Exercise of the 30th Round of Stock Options
2010/01/25
Amendment of Notice for Large Volume Exercise of the 30th Round of Stock Options
2010/01/18
Notice for Large Volume Exercise of the 30th Round of Stock Options
<
21
22
23
24
25
26
27
28
29
>